TrialJournal of clinical pharmacology2016

UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.

Cody J Peer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.